Post-myocardial Infarction Prophylaxis
📧 Sign up to get email alerts when something new happens for Post-myocardial Infarction Prophylaxis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-03-28FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application from Zydus Lifesciences Limited for Atenolol under ANDA 076900. This confirms approval of a gene…
-
FDA approval · 2007-09-11FDA Approved: METOPROLOL TARTRATE — Original Application (Aurobindo Pharma Limited)
FDA approved metoprolol tartrate as an original application generic product for Aurobindo Pharma Limited.